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AbstrACt
Introduction The rising prevalence of modifiable risk 
factors (eg, obesity, hypertension and physical inactivity) 
is causing an increase in possible avoidable complications 
in patients undergoing cardiac surgery. This study 
aims to assess whether a combined preoperative and 
postoperative multidisciplinary cardiac rehabilitation 
(CR) programme (Heart-ROCQ programme) can improve 
functional status and reduce surgical complications, 
readmissions and major adverse cardiac events (MACE) as 
compared with standard care.
Methods and analysis Patients (n=350) are randomised 
to the Heart-ROCQ programme or standard care. The 
Heart-ROCQ programme consists of a preoperative 
optimisation phase while waiting for surgery (three times 
per week, minimum of 3 weeks), a postoperative inpatient 
phase (3 weeks) and an outpatient CR phase (two times 
per week, 4 weeks). Patients receive multidisciplinary 
treatment (eg, physical therapy, dietary advice, 
psychological sessions and smoking cessation). Standard 
care consists of 6 weeks of postsurgery outpatient CR 
with education and physical therapy (two times per week). 
The primary outcome is a composite weighted score of 
functional status, surgical complications, readmissions and 
MACE, and is evaluated by a blinded endpoint committee. 
The secondary outcomes are length of stay, physical and 
psychological functioning, lifestyle risk factors, and work 
participation. Finally, an economic evaluation is performed. 
Data are collected at six time points: at baseline (start of 
the waiting period), the day before surgery, at discharge 
from the hospital, and at 3, 7 and 12 months postsurgery.
Ethics and dissemination This study will be conducted 
according to the principles of the Declaration of Helsinki 
(V.8, October 2013). The protocol has been approved by the 
Medical Ethical Review Board of the UMCG (no 2016/464). 
Results of this study will be submitted to a peer-reviewed 
scientific journal and can be presented at national and 
international conferences.
trial registration number NCT02984449.
IntroduCtIon
The leading cause of death in Western 
countries is ischaemic heart disease.1 One 
of the treatments for severe ischaemic 
heart disease is cardiac surgery. The risk 
of postoperative complications related 
to cardiac surgery is substantial; pulmo-
nary complications (up to 33%), delirium 
(~26%) and arrhythmias (~30%) have been 
reported to occur.2–4 These complications 
are associated with prolonged hospitalisa-
tion, increased adverse events (ie, read-
mission, stroke, myocardial infarction and 
mortality), reduced health-related quality of 
strengths and limitations of this study
 ► This is a prospective, randomised, open, blinded 
endpoint trial.
 ► This study is a comparison of a unique multidisci-
plinary preoperative and postoperative cardiac re-
habilitation (CR) programme with a standard care 
postoperative outpatient CR programme.
 ► The study is patient-oriented; primary and second-
ary outcomes provide a comprehensive and clini-
cally relevant evaluation of patients’ recovery from 
surgery (eg, on physical, psychological and social 
domains).
 ► Both short-term and long-term effects of the CR pro-
grammes are included.
 ► This is a single-centre study, although patients are 
referred from four hospitals.
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life (HRQoL) and higher healthcare costs.5–10 Patients 
with poor dietary habits (present in ~80% of the candi-
dates for cardiac surgery), who are physically inactive 
(~45%), who smoke (22%), or who experience depres-
sion and/or anxiety disorders (~30%) are at higher risk 
for postoperative complications and are at risk for lack 
of functional benefits after cardiac surgery.8 11–19
Over the last decades risk factors such as age, 
obesity, diabetes, hypertension and dyslipidaemia 
have steadily increased in patients undergoing cardiac 
surgery.20 21 Despite their adverse effects on treatment 
outcomes, reducing the burden of modifiable risk factors 
is currently not part of standard clinical care before and 
after cardiac surgery. Before cardiac surgery, patients 
often have a preoperative period of several weeks on the 
waiting list in which they receive little or no guidance. This 
waiting period has been associated with increased psycho-
logical stress, feelings of anxiety and reduced functional 
status.22 23 With respect to inactivity during hospitalisation 
after cardiac surgery, research has shown that during the 
8–11 days of hospitalisation, patients spent the majority of 
their time sitting or in a supine position.24 25 In-hospital 
physical inactivity is a predictor of a longer hospital stay 
and rehospitalisation.24 26 27 It causes a decrease in muscle 
strength and aerobic capacity, both fundamental in the 
performance of activities of daily living.28 29 This reduced 
physical capacity may seriously impact independence, 
especially since these patients are often elderly and the 
functioning of their entire physiological system is already 
reduced.30
The goal of cardiac rehabilitation (CR) is to improve 
the preoperative and postoperative status of patients 
undergoing cardiac surgery. CR aims ‘to favourably influ-
ence the underlying cause of cardiovascular disease, as 
well as to provide the best possible physical, mental, and 
social conditions’.31 Postoperative CR is already an essen-
tial part of standard care in the Netherlands, although 
many hospitals in the Netherlands provide a phase II 
outpatient CR programme starting 3–6 weeks after cardiac 
surgery.32 33 Benefits of postoperative CR are reported for 
a variety of cardiac patients34; however, the evidence in 
patients undergoing cardiac surgery is still lacking with 
regard to patient-relevant outcomes and mortality.35 
In addition to postoperative CR, small trials suggested 
that preoperative CR is effective in reducing postopera-
tive pulmonary complications, duration of hospital stay, 
improving HRQoL and physical fitness, and increasing 
the compliance to postoperative CR.23 36 37 However, 
long-term effects and the effects on other complications 
remain unclear. Furthermore, most studies investigated 
the effect of preoperative CR or postoperative CR, but not 
the effect of both CR methods combined. The hypoth-
esis is that a combined preoperative and postoperative 
CR programme is more beneficial when compared with a 
separate preoperative CR programme or a single postop-
erative CR programme.
The aim of the Heart-ROCQ (Heart Rehabilitation in 
patients awaiting Open heart surgery targeting to prevent 
Complications and to improve Quality of life) study 
is to determine the effect of a comprehensive preop-
erative and postoperative CR programme (the Heart-
ROCQ programme) on functional status, postoperative 
surgical complications, readmissions to hospital and 
major adverse cardiac events (MACE) compared with a 
regular Dutch postoperative outpatient CR programme 
(the standard care CR programme).32 In addition, the 
effect of the Heart-ROCQ programme on physical and 
psychological functioning, including HRQoL, lifestyle 
risk factors, work participation and cost-effectiveness, 
is evaluated in comparison with the standard care CR 
programme. To assess who will benefit from CR and why 
the CR programme is effective, moderator and mediator 
analyses are performed.
MEthods And AnAlysIs
study design and organisation
This investigator-initiated, prospective, randomised, open, 
blinded endpoint trial is executed in a single centre 
(University Medical Center Groningen (UMCG)). Patients 
from three referral hospitals (Ommelander Hospital 
Groningen, Martini Hospital Groningen and Wilhelmina 
Hospital Assen) who are accepted for cardiac surgery at 
the UMCG are also approached to participate. Patients are 
randomly assigned to a combined preoperative and postop-
erative multidisciplinary CR programme (the Heart-ROCQ 
group) or a regular phase II outpatient CR programme after 
surgery (the Standard Care group).32 Figure 1 provides an 
overview of the study design.
Ethical considerations and dissemination
The study has been registered at  ClinicalTrials. gov. If 
applicable, substantial amendments will be notified to the 
Medical Ethical Review Board (METc) for approval, and 
changes will be written into articles describing the results of 
the study. Results of this study will be submitted to a peer-re-
viewed scientific journal and can be presented at national 
and international conferences.
Participants
Patients (≥18 years) admitted for elective coronary 
artery bypass grafting (CABG), valve surgery, aortic 
surgery or combined procedures are eligible. Patients 
accepted for congenital procedures, transcatheter 
aortic valve implantations, aortic dissections or aortic 
descending repair are excluded. Other exclusion 
criteria are inability to participate in all programme 
elements of the Heart-ROCQ programme due to disor-
ders of the nervous or musculoskeletal system that 
limit exercise capacity, chronic obstructive pulmonary 
disease with Global Initiative for Chronic Obstructive 
Lung Disease criteria classification 3 or 4,38 addiction 
to alcohol or drugs, a serious psychiatric illness (ie, 
recently experienced psychosis, bipolar disorder, diag-
nosis of schizophrenia, serious cognitive or neurological 
problems, and acute suicidal ideations or behaviour), 
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Figure 1 Research design of the Heart-ROCQ prospective, randomised, open, blinded endpoint trial. The phases of both 
cardiac rehabilitation programmes and the measurements are shown relative to the moment of surgery. Heart-ROCQ, Heart 
Rehabilitation in patients awaiting Open heart surgery targeting to prevent Complications and to improve Quality of life.
or when it is undesirable to exercise (ie, hypertrophic 
cardiomyopathy, unstable angina, advice from cardiol-
ogist); any treatment which is planned during one of 
the CR programmes and which is expected to interrupt 
attendance to the CR programme (eg, planned organ 
transplantation, preoperative endocarditis, planned 
chemotherapy and so on); playing a sport at the (inter)
national level; and being unable to read, write or under-
stand Dutch.
study enrolment, randomisation and registry
Figure 2 shows the flow chart of the Heart-ROCQ study. 
Patients on the waiting list of the thoracic surgery depart-
ment and meeting the study criteria for type of surgery are 
asked by their cardiologist to participate. The cardiologist 
provides the patients with study information and an invi-
tation to meet the researcher at the preoperative consul-
tation. At the preoperative consultation, the researcher 
will obtain informed consent and conduct the baseline 
measurements. Eligible patients who have signed informed 
consent and performed the baseline measurements are 
randomised to the Heart-ROCQ group or Standard Care 
group. Randomisation (concealed group allocation in 
REDCap, random blocks of 2–4, 1:1 ratio) is stratified for 
weight of the surgery (isolated CABG, single non-CABG 
(ie, replacement or repair of part of aortic or valve), two 
procedures or three procedures), gender and age (≥65 and 
<65 years). Prior to the start of the study, the randomisation 
lists were created (using the ‘ralloc’ function of Stata/SE 
V.13.0) and imported into the secure data collection tool 
REDCap (V.7.3.2) by an independent researcher. Medical 
staff and researchers are not blinded to group allocation 
due to logistic reasons. The primary endpoint is evaluated 
by an independent endpoint committee blinded to group 
allocation.
Patients who are not willing to participate are asked 
to give written consent for using data that are collected 
during routine care. The data are collected in the Heart-
ROCQ study registry to increase insight into potential 
differences between patients who participated in the 
study and patients who did not. The Heart-ROCQ registry 
will thus provide more insights into the generalisability 
of the results. Data from this registry are not used for the 
primary statistical analyses.
Intervention
Heart-ROCQ group
The Heart-ROCQ group receives a CR programme at 
the Centre for Rehabilitation of the UMCG (Beatrix-
oord location, which is located 6 km from the hospital 
of the UMCG) consisting of three phases. The first phase 
is an outpatient preoperative optimisation phase during 
the waiting period (three times per week, minimum of 
3 weeks). The second phase is a postoperative inpatient 
CR phase (3 weeks, weekdays only), followed by the third 
phase, an outpatient CR phase (two times per week, for 
4 weeks). During each phase, all participants receive 
physical therapy including group sessions of inspiratory 
muscle training,39 strength training, aerobic cycling, 
breathing, coughing and relaxation. In addition, patients 
have an assessment with a dietitian and a psychologist 
and take part, when indicated, in individual sessions to 
optimise their health. In addition, different group educa-
tion sessions are organised regarding coping with stress, 
awareness of risk factors and maintaining a healthy life-
style. Two additional modules, namely coaching to stop 
smoking and to return to work, are available for patients 
who, respectively, smoke or are employed. A detailed 
description of the CR programme is given in the online 
supplementary information.
Standard Care group
In the Netherlands, the current standard of care 
consists of a phase II outpatient CR programme which 
is conducted at the referred hospital.32 33 In general, 
this CR programme starts 3–6 weeks after discharge 
from the hospital and lasts for 6 weeks. The programme 
consists of four educational sessions (regarding risk 
factors and retaining a healthy lifestyle) and physical 
therapy (two times per week: 30 min cycling, together 
with 30 min sports and games, relaxation therapy, 
or strength training). Furthermore, patients can be 
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Figure 2 Flow chart of the Heart-ROCQ study. CR, cardiac rehabilitation;Heart-ROCQ, Heart Rehabilitation in patients 
awaiting Open heart surgery targeting to prevent Complications and to improve Quality of life; TAVI, transcatheter aortic valve 
implantation.
referred to a psychologist or a dietitian when needed. 
The content of this CR programme is based on the 
Dutch CR guidelines.40
Composite primary endpoint: functional status, complications 
and events
The primary outcome is a composite weighted score of 
functional status, postoperative surgical complications, 
readmissions to the hospital and MACE. Each event is 
scored (ranging from 1 to 3 points) separately. Table 1 
shows an overview of the primary outcome and the 
scoring system.
The scores of all events are combined to calculate a total 
score. Only the most serious complication is counted per 
event (eg, when a percutaneous coronary intervention 
(score 1) is complicated by a stroke (score 2), the score 
will be 2 and not 3 (1+2)).
The concept of the composite weighted score is 
adapted from the African-American Heart Failure Trial.41 
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Table 1 Definitions and score of the components of the composite primary endpoint
Functional status Score
Worsening in physical functioning (domain score of health-related quality of life, RAND-36 V.2).* 1
No change or improvement in physical functioning.* 0
Worsening in physical problem (domain score of health-related quality of life, RAND-36 V.2).* 1
No change or improvement in physical problem.* 0
A clinically relevant worsening is classified as minimal change according to Wyrwich et al.59
(Serious) adverse events
No serious adverse event. 0
Prolonged mechanical ventilation 1
  Mechanical ventilation longer than 24 hours.
Lung infection 1
  (1) A new lung radiographic infiltrate and (2) two signs that the infiltrate is of infectious origin—that is, (a) fever: body temperature 
>38°C or <36°C; (b) leucocytosis—white cell counts >10×109/L or <4×109/L; (c) positive sputum culture; and/or (d) decline in 
oxygenation.
Delirium 1
  (1) A DOS60 score ≥3 at hospital ward and/or (2) diagnosis confirmed by a psychiatrist, geriatrist or supervising specialist 
according to the DSM-IV criteria resulting in treatment with medication.
Readmissions to intensive care unit 1
  Unrelated to a secondary endpoint.
Deep wound infection 2
  Deeper tissues are affected (muscle, sternum and mediastinum) and must include (1) surgical drainage/refixation or (2) an 
organism is isolated from culture of mediastina tissue or fluid, or (3) antibiotic treatment because of sternum wound.
Readmissions to hospital 1
  An unplanned hospital stay with different dates of admission and discharge with a medical indication (ie, clinical signs and 
symptoms or change of treatment).
Any cardiothoracic surgical interventions 2
  Graft or valve failure, CABG, valve, aortic or other cardiac surgery.†
Any percutaneous interventions 1
  PCI, TAVI and so on.
Myocardial infarction 2
  According to the third universal definition of myocardial infarction.‡
Cerebral vascular accident / stroke 2
  Acute neurological event of at least 24 hours in duration, with focal signs and symptoms and without evidence supporting any 
alternative explanation. Diagnosis of stroke requires confirmation by CT, MRI or pathological confirmation.
Sudden death survivor 2
  The sudden onset of symptoms, such as chest pain and cardiac arrhythmias, and ventricular tachycardia, which lead to the loss of 
consciousness and cardiac arrest followed by reanimation and does not lead to biological death.
Death 3
  All-cause mortality.
Total score = sum of physical status and SAEs at 3 months and 1 year (worst score of each event).
In violet, postoperative complications can be scored once.
*Compared with baseline.
†According to the definitions of the ‘Begeleidingscommissie Hartinterventies Nederland’.
‡Thygesen et al.61
CABG, coronary arterial bypass grafting;DOS, Delirium Observation Screening scale;DSM, Diagnostic and statistical manual of mental disorders; 
PCI, percutaneous coronary intervention;RAND-36 V.2, Medical Outcome Study 36-item General Health Survey; SAE, serious adverse event; TAVI, 
transcatheter aortic valve implantation.
Functional status is assessed through two health domains 
of the Medical Outcomes Study 36-item General Health 
Survey (RAND-36 V.2)42: physical functioning and phys-
ical health problems. The primary endpoint is evaluated 
at 3 months (T4) and 1 year (T6) after surgery (figure 1). 
Deep wound infections and surgical re-explorations are 
screened up to 120 days after surgery. Other postoper-
ative surgical complications are measured in the period 
between the surgery and when a patient meets the 
UMCG discharge criteria (box 1). Hospital admissions 
are checked between baseline and 1 year after surgery. 
To prevent bias (since the Heart-ROCQ group follows the 
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box 1 discharge criteria of the university Medical Center 
Groningen
 ► No drain, no external pacemaker lead, no infusion or oxygen present.
 ► Stable clinical conditions (stable lab results, X-ray and haemody-
namic parameters).
 ► Able to perform basic activity of daily living activities (ie, going inde-
pendently to the toilet).
Table 2 Definitions of the secondary complications and events
Definitions Time of measure
Atrial fibrillation Surgery to T3
  New onset of atrial fibrillation or atrial flutter requiring medical treatment or cardioversion.
Prolonged ICU stay Initial stay
  When the number of calendar days is two or more from ICU admission to discharge.
Readmissions to hospital Baseline to T6*
  The number of unplanned hospital stays with different dates of admission and discharge with a 
medical indication (ie, clinical signs and symptoms or change of treatment).
  a. Directly related to a cardiac cause.
  b. Not directly related to a cardiac cause.
Hospitalisation days Baseline to T6*
  Total number of days of hospitalisation.
  a. Directly related to a cardiac cause.
  b. Not directly related to a cardiac cause.
Cardiovascular death Baseline to 5 years after 
surgery  Any death due to proximate cardiac or cardiovascular cause (eg, myocardial infarct, low-output 
failure, fatal arrhythmia, death secondary to a cerebral vascular accident, pulmonary embolism, 
ruptured or dissecting aortic aneurysm, or other vascular diseases), unwitnessed death, and 
death of unknown cause, and all procedure-related deaths (eg, PCI, CABG), including those 
related to concomitant treatment†.
Non-cardiovascular death Baseline to 5 years after 
surgery  Any death not covered by the above definition, such as death caused by infection, malignancy, 
sepsis, pulmonary causes, accident, suicide or trauma.
Concerning safety   
Surgical re-exploration for bleeding/ tamponade Surgery to T4
  Surgical incision into the sternum as a result of a bleeding or tamponade.
  a. Acute: presented within 24 hours after surgery.
  b. Late: presented after 24 hours after surgery.
Surgical re-exploration dehiscence Surgery to T4
  Aseptic wound dehiscence.
*Not measured between the day of admission before surgery and 30 days after surgery because of POST-in phase of the Heart-ROCQ 
programme.
†Specifically, any unexpected death even in patients with coexisting, potentially fatal non-cardiac disease (eg, cancer, infection) will be 
classified as cardiac death.
CABG, coronary artery bypass grafting; Heart-ROCQ, Heart Rehabilitation in patients awaiting Open heart surgery targeting to prevent 
Complications and to improve Quality of life; ICU, intensive care unit; PCI, percutaneous coronary intervention; T4, follow-up at 3 months after 
surgery; T6, follow-up at 12 months after surgery.
inpatient CR phase after surgery), hospital admissions 
between the day of admission before surgery and 30 days 
after surgery are not included when determining the 
(calculated) primary endpoint.
secondary outcomes
Complications and events
All individual components of the composite endpoint 
regarding the complications and events will be analysed 
separately as secondary outcomes. Table 2 summarises the 
definitions of the secondary complications and events, 
including at the time of screening.
All documents concerning the composite primary 
endpoint and the secondary complications are encrypted 
and subsequently adjudicated by the independent 
endpoint committee. The endpoint committee consists 
of four members (cardiologists and cardiothoracic 
surgeons) who are not employed in the UMCG and are 
blinded to group allocation.
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Table 3 Time of measure, physical tests and questionnaires of the secondary outcomes
Secondary outcomes Measure Time of measure
Physical health
  Cardiorespiratory fitness 6MWT62 T1–T4, T6
  Muscle strength STS-10, grip and leg strength63 64 T1–T4, T6
  Independence in ADL KATZ65 66 T1, T4, T6
Psychological health
  General anxiety GAD-767 T1, T2, T4, T6
  Feelings of depression PHQ-968 69 T1, T2, T4, T6
  Health-related quality of life RAND-36 V.242 T1, T4, T6
Lifestyle risk factors
  Physical activity iPAQ70 and Actigraph*71 T1, T4, T6
  Obesity indices BMI, waist to hip ratio T1, T4, T6
  Smoking behaviour Number of cigarettes per day T1, T4, T6
Economic evaluation
  Healthcare use and related medical costs iMCQ72 T1, T4–T6
  Work participation† iPCQ73 T1, T4–T6
  QALYs EQ-5D-5L52 T1, T4–T6
Potential mediators
  Cardiac self-efficacy CSE45 T1, T2, T4, T6
  Illness representations IPQ-R43 T1, T2, T4, T6
*Patients are asked to wear the Actigraph during waking hours for one consecutive week.
†Health-related productivity losses of paid work and unpaid work.
ADL, activities of daily living; BMI, body mass index; CSE, cardiac self-efficacy; EQ-5D-5L, EuroQol Five-Dimensional Questionnaire; GAD-7, 
Generalised Anxiety Disorder 7-item scale; iMCQ, iMTA Medical Cost Questionnaire; iPAQ, International Physical Activity Questionnaire; iPCQ, 
iMTA Productivity Cost Questionnaire; IPQ-R, Illness Perception Questionnaire, Revised; KATZ, Katz Index of Independence in Activities of 
Daily Living; 6MWT, 6 min walking test; PHQ-9, Patient Health Questionnaire 9-item scale; QALY, quality-adjusted life years; RAND-36 V.2, 
Medical Outcome Study 36-item General Health Survey; STS-10, 10 times sit to stand test; T1, begin of waiting time; T2, 1–8 days before 
surgery; T3, moment that patients meet the University Medical Center Groningen discharge criteria; T4–T6, follow-up at 3, 7 and 12 months 
after surgery.
Questionnaires and physical tests
Table 3 shows the physical tests and questionnaires of the 
secondary outcomes regarding physical and psycholog-
ical health, lifestyle risk factors, and the economic eval-
uation. Physical tests and questionnaires are completed 
at six assessment points (figure 1). The preoperative 
measurements (T1 and T2) are conducted at the start 
(preoperative consultation) and the end (1–8 days 
before surgery) of the waiting period. The third measure-
ment (T3) is performed when patients meet the UMCG 
discharge criteria (box 1). The follow-up measurements 
(T4, T5 and T6) are at 3, 7 and 12 months after surgery. 
Patients are asked to fill in questionnaires online, or when 
requested on paper prior to the visits for the physical tests. 
All adverse events reported spontaneously by the patient 
or observed by the investigator are recorded. In addition, 
serious adverse events are reported to the METc. Data are 
stored in REDCap and on a secure drive at the CardioRe-
search department in the UMCG. Two times per year, the 
study is monitored by a trained research monitor from 
another department of the UMCG. Details of procedures, 
data collection, management and monitoring can be 
found in the Trial Master File of the Heart-ROCQ study 
(can be obtained by the investigators). On 12 June 2018, 
the study was audited and certified for ISO 9001:2015 
independently by DNV GL.
Potential moderators
Preoperative risk profile (ie, Euroscore ӀӀ, medical 
history, lifestyle risk factors, and physical and mental 
status), surgery parameters and demographics are 
collected from the medical record and baseline measure-
ments. The content of the CR programme is described in 
terms of compliance, duration of CR programme, type 
of treatment, frequency and training load (ie, for bicycle 
training: external workload, heart rate response, and 
rate of perceived exertion using the Borg Scale; and for 
strength training: sets, repetitions and intensity) for both 
the Heart-ROCQ group and the Standard Care group.
Potential mediators
Illness perceptions (ie, patients’ mental representations 
of their illness based on different sources of information) 
are measured with three subscales (personal control, 
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treatment control and consequences) of the Revised 
Illness Perception Questionnaire.43 These subscales are 
chosen because of their sensitivity to change and because 
of their relation to psychological distress.44 The Cardiac 
Self-Efficacy (CSE) Scale45 is used to measure CSE (ie, 
patients’ confidence to perform a specific task related to 
cardiac disease).
statistical analyses
Sample size
Assuming a normal distribution, the mean weighted 
score of the primary endpoint is estimated at 1.0 with an 
SD of 0.9 at 1 year after surgery. This estimation is based 
on historical data of the UMCG, an unpublished ongoing 
pilot study in the UMCG, the Dutch registration data-
base46 and data reported in the literature.6 47–49 A decrease 
of 0.3 is expected in the Heart-ROCQ group, based on 
previous studies comparing CR with standard care36 48 50 
(ie, no CR), and is considered to be clinically relevant (ie, 
on average a 30% decrease in complications/events or 
worsening in functional status, or 10%–20% decrease in 
MACE or death). To detect this decrease and achieve 80% 
power (significance level of 5%), a group of 286 patients 
(143 in the Heart-ROCQ group and 143 in the Standard 
Care group) is needed. To incorporate a withdrawal of 
±20%, a total sample size of 350 is needed at baseline.
Interim analysis
An interim analysis will be conducted when 40% of the 
included patients have had the measurements 1 year after 
surgery. The study will be terminated prematurely when 
the primary outcome of one of the CR programmes is obvi-
ously (p<0.001) different from the other CR programme.
Primary and sensitivity analyses
All endpoints are primarily analysed according to the 
‘intention-to-treat’ principles, and missing values are 
counted as worst-case score (nominal variables) or esti-
mated using maximum likelihood estimation (interval 
variables). As supplementary analyses, the endpoints are 
analysed on a per-protocol principle with and without 
using imputation methods for missing values. In all 
analyses, a two-sided p<0.05 is considered statistically 
significant.
The total score of the primary endpoint will be handled 
as a continuous variable. All continuous variables will be 
analysed using linear mixed models to determine ‘time x 
group’ differences. Significant interactions will be further 
explored using the Bonferroni post-hoc test to determine 
differences between each time point. Non-parametric 
tests will be used if the assumptions of normal distribu-
tion are violated. More information about the statistical 
methods and clinical relevance are written in the research 
protocol ( ClinicalTrials. gov: NCT02984449).
Economic evaluation
For the evaluation of healthcare utilisation, standard 
prices published in the Dutch costs guidelines are 
used.51 To compare the costs with quality-adjusted life 
years (QALYs), QALYs are estimated with the use of the 
EuroQol Five-Dimensional Questionnaire (EQ-5D-5L).52 
Utility values for the EQ-5D-5L are calculated based on the 
new Dutch tariff.53 Results from the analysis are reported 
as an incremental cost-effectiveness ratio, dividing the 
difference in effect by the difference in costs. Bootstrap 
resampling will be performed, and cost-effectiveness 
acceptability curves will be plotted, to estimate the prob-
ability that the Heart-ROCQ programme is cost-effective 
when compared with standard care. A societal perspective 
is applied.
study status
From May 2017 to December 2018, 75 patients were 
enrolled. In the following years we expect that the enrol-
ment will increase to 85 patients per year. The last patient 
is expected to be included in July 2021.
Patient and public involvement
In a pilot study (to be submitted), patient satisfaction 
and feasibility (in terms of accessibility, compliance, 
training load and safety) of the Heart-ROCQ programme 
have been evaluated. Patients were very satisfied with 
the programme, scoring it 8 out of 10; therefore, we did 
not change the content of the programme. However, 
patients’ rate of perceived exertion was generally quite 
low and no serious adverse events occurred during the 
bicycle training. For safety reasons the intensity was not 
increased. However, in order to estimate the maximum 
load more accurately and better tailor the programme 
to the individual, we decided to change one of the stop 
criteria of the preoperative submaximal ergometry test 
from 70% to 90% of the expected maximal heart rate. 
Furthermore, our outcomes are, among others, based on 
the reasons why patients recommended the programme 
to other patients. For example, patients reported that 
their self-efficacy and physical capacity were improved, 
so we added the CSE questionnaire and physical tests 
to objectively measure these outcomes. In this way the 
results were taken into account in the further develop-
ment of the Heart-ROCQ programme and the protocol 
of this study. The results of this trial will be distributed 
by various information channels (eg, websites of cardiac 
patient organisations, social media). Two to three times a 
year, we provide a newsletter about the progress, and (in 
the end) the results of the study are sent to patients who 
are interested.
dIsCussIon
The Heart-ROCQ study is the first randomised clinical 
trial evaluating the effect of a combination of preoper-
ative and postoperative CR programme compared with 
a postoperative CR programme. Unlike the vast majority 
of CR programmes in previous studies, the current 
programme is multidisciplinary, targeting different 
aspects of surgical outcomes in patients undergoing 
cardiac surgery. Because different aspects are targeted, a 
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composite weighted score will better reflect the treatment 
benefits than a single outcome. Therefore, the primary 
endpoint is a composite endpoint of functional status, 
postoperative surgical complications, readmissions to the 
hospital and MACE. The components of the endpoint 
are of clinical importance to patients undergoing cardiac 
surgery and reflect a comprehensive representation of 
the recovery of the patient.
Both the ideas of the combined primary endpoint 
and the weighting of the individual components were 
derived from other studies.41 54 55 Assigning different 
weights to the components was needed for more accu-
rate comparison. Since the components are not equal 
in clinical importance, equal weights would lead to 
inaccurate statistical analysis.55 In the current study, the 
weighted score of HRQoL is lower (1 point instead of 2 
points) to minimise bias due to patients’ knowledge of 
group allocation. Therefore, improvements in quality of 
life are not counted in the primary endpoint to prevent 
bias in a positive direction. This also prevents that a 
score in quality of life and an adverse event cancel each 
other out (eg, when a patient experiences an improve-
ment in quality of life (+2 points) and has a stroke (−2 
points), then the total score is 0). The scores of all-cause 
mortality, stroke, myocardial infarction and revascular-
isation are in line with the results shown by Tong and 
colleagues.55 A disadvantage of composite endpoints 
is that the effect may be driven by complications that 
occur with the greatest frequency.56 Therefore, postop-
erative complications which occur frequently, such as 
atrial fibrillation, are evaluated separately as secondary 
endpoint. The primary endpoint is evaluated by an 
endpoint committee, which is blinded to group alloca-
tion and consists of four independent cardiologists and 
cardiothoracic surgeons.
Previous preoperative CR studies were primarily 
focused on short-term effects; only one preoperative 
CR study and a few postoperative CR studies have deter-
mined long-term effects.23 35 36 57 In contrast to previous 
preoperative CR studies, the Heart-ROCQ study sets out 
to investigate both short-term and long-term effects of 
the CR programmes.23 35 36 Due to the trends in, among 
others, increasing age, obesity and physical inactivity, 
patients undergoing cardiac surgery are becoming more 
complex. The Heart-ROCQ programme aims to address 
these issues, which makes the programme clinically 
relevant for all cardiac surgery patients. Therefore, we 
chose to include different types of cardiac surgery. Since 
different moderators and mediators are assessed before, 
during and after CR, we can explore which factors are 
associated with better outcomes and which working mech-
anisms contribute to its effectiveness. These findings may 
provide a more indepth understanding of who benefits 
the most from CR in both the short and long term and 
the underlying mechanisms of CR, which are still not fully 
understood in patients undergoing cardiac surgery.35 In 
addition, the present study is thought to considerably 
contribute to the evidence to further develop guidelines 
for clinical practice, especially regarding the preoperative 
CR programme.58
The Heart-ROCQ programme is expected to be cost-ef-
fective in the long term, which is also of interest for 
policymakers and healthcare providers. Therefore, an 
economic evaluation is performed to assess the cost-effec-
tiveness of CR, since little is known about the cost-effec-
tiveness of CR.48 A societal perspective of this economic 
evaluation is chosen, meaning that healthcare costs and 
patient-related and productivity-related costs and benefits 
are taken into account. If the Heart-ROCQ programme 
is proven to be effective, it might be advisable to include 
a supportive prevention-oriented waiting period prior to 
surgery as an integral part of the treatment for patients 
undergoing elective cardiac surgery. This implies a para-
digm shift from curative care following cardiac surgery 
to an additional preventive care attitude before surgery. 
Extensions of rehabilitation options in or in the vicinity of 
cardiac centres will then be required.
The Heart-ROCQ study is the first randomised clinical 
trial comparing the effect of a combined preoperative and 
postoperative CR programme with a regular Dutch phase 
II postsurgery outpatient rehabilitation CR programme 
in a population undergoing elective cardiac surgery. This 
study is expected to provide new understanding of the 
effectiveness and underlying working mechanisms of CR, 
and subsequently to improve value-based healthcare.
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